Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Methylthioninium

EU orphan designation number: EU/3/10/804   
Active ingredient: Methylthioninium
Indication: Treatment of progressive supranuclear palsy
Sponsor: Prof. Claude Wischik
TauRx Therapeutics, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/12/2010 Orphan designation EMA/OD/076/10 (2010)8588 of 26/11/2010
17/02/2012 Transfer of orphan designation EMA/OD/076/10/T/01 (2012)1104 of 15/02/2012